GYRE THERAPEUTICS, INC. Balance Sheet
GYRE / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
GYRE THERAPEUTICS, INC. had $166M in total assets and $106M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37.1M | $11.8M | $33.5M | $25.2M | $44.3M | $30.4M | $15.4M | $31.2M | $14.5M | $10.3M | $29.1M | $1.5M | $2.8M | $3.4M | $83.9M |
| Accounts Receivable | $31.1M | $19.6M | - | - | $1.8M | $3.3M | $15.0M | - | - | - | - | - | - | - | - |
| Inventory | - | $6.3M | $4.3M | $6.1M | - | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $102.4M | $64.8M | $57.2M | $49.7M | $51.5M | $89.5M | $96.1M | $124.0M | $39.1M | $37.5M | $68.7M | $2.1M | $93.6M | $127.7M | $198.7M |
| PP&E (Net) | $23.6M | $23.9M | $23.3M | $17.7M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | $682.0K | $1.6M | - |
| Total Assets | $166.1M | $125.4M | $116.5M | $84.8M | $55.7M | $94.8M | $98.6M | $124.9M | $39.5M | $38.1M | $69.5M | $3.0M | $145.9M | $189.6M | $258.1M |
| Current Liabilities | $18.3M | $19.5M | $20.0M | $12.2M | $14.2M | $17.8M | $28.9M | $4.8M | $8.7M | $22.0M | $37.8M | $2.3M | $11.0M | $11.3M | $78.6M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | $0 | $1.1M | $2.0M | $2.0M |
| Shareholders' Equity | $106.0M | $63.3M | -$15.8M | $72.2M | $41.1M | $68.3M | $68.3M | $119.9M | $30.8M | $16.1M | $31.4M | -$109.4M | -$103.0M | -$93.3M | $69.0M |